The height of divisiveness? Drug to tackle dwarfism irks little people
Vosoritide could allow kids with achondroplasia to grow at the normal rate, but some aren’t impressed
Dwarves are divided over the prospect of a drug that could fight the condition by helping children with the genetic abnormality grow at almost the normal rate.
An American biotech firm, Bio-Marin, has submitted the results from trials of vosoritide to US and European regulators, making its release possible within months.
Dwarfism is defined as an adult height of less than 1.5m. It affects about one in 25,000 infants...